Herranz Amo F, Díez Cordero J M, Verdú Tartajo F, Bueno Chomón G, Leal Hernández F, Bielsa Carrillo A, García Burgos J
Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, España.
Arch Esp Urol. 1998 Jun;51(5):437-41.
To evaluate the incidence of transition zone prostate cancer in patients with symptoms of benign prostatic hyperplasia, elevated PSA values, negative DRE and central and transition zone biopsies in order to determine the risk factors in the subgroup of patients with a high incidence of transition zone prostate cancer.
Of 541 patients with benign histological findings on ultrasound-guided transrectal prostatic peripheral and central zone biopsies, 125 (23%) underwent prostatic surgery. The mean age was 68.2 +/- 6.8 years, the mean PSA value was 16.5 +/- 25.9 ng/ml (Hybritech).
Transition zone prostate cancer was found in the surgical specimen of 11.2% of the patients. No significant differences were found between patients with and without cancer for age, PSA and PSAD values, prostate size, nodules on ultrasound, or number of biopsies performed. Patients with stage Tb1 prostate cancer showed much higher PSA levels than those with stage T1a cancer (p = 0.06). Only one stage T1a cancer was found (4%) in patients < or = 70 years with PSA values < or = 10 ng/ml, while 12.5% of the cancers were found in patients < or = 70 years with PSA > 10 ng/ml (p = 0.2).
The incidence of transition zone prostate cancer in this series was 11.2%. The incidence of cancer and the probability of tumor progression are higher in the subgroup of patients < or = 70 years with PSA > 10 ng/ml. Hypothetically, had ultrasound-guided transition zone biopsies been performed in this subgroup of patients, one case of stage T1a prostate cancer (11%) would not have been diagnosed but biopsy would have been avoided in 41% of the patients.
评估良性前列腺增生症状、前列腺特异性抗原(PSA)值升高、直肠指检(DRE)阴性且中央区和移行区活检的患者中移行区前列腺癌的发生率,以确定移行区前列腺癌高发患者亚组的危险因素。
在541例经超声引导经直肠前列腺外周和中央区活检组织学结果为良性的患者中,125例(23%)接受了前列腺手术。平均年龄为68.2±6.8岁,平均PSA值为16.5±25.9 ng/ml(Hybritech)。
11.2%的患者手术标本中发现移行区前列腺癌。有癌和无癌患者在年龄、PSA和前列腺特异性抗原密度(PSAD)值、前列腺大小、超声结节或活检次数方面未发现显著差异。Tb1期前列腺癌患者的PSA水平显著高于T1a期癌症患者(p = 0.06)。在年龄≤70岁、PSA值≤10 ng/ml的患者中仅发现1例T1a期癌症(4%),而在年龄≤70岁、PSA>10 ng/ml的患者中有12.5%发现癌症(p = 0.2)。
本系列中移行区前列腺癌的发生率为11.2%。在年龄≤70岁、PSA>10 ng/ml的患者亚组中,癌症发生率和肿瘤进展概率更高。假设对该亚组患者进行超声引导下的移行区活检,1例T1a期前列腺癌(11%)将不会被诊断出来,但41%的患者可避免活检。